Abstract
Recent studies reported favorable angiographic and clinical outcomes after everolimus-eluting stent (EES) implantation. However, there were no studies to assess vascular responses after EES implantation using optical coherence tomography (OCT). Therefore, the OCT findings in EES were investigated and compared with those in sirolimus-eluting stent (SES). Follow-up OCT studies were performed in 110 lesions (40 EES and 70 SES) of 104 patients at 9 months after stent implantation. The strut apposition, neointimal hyperplasia (NIH) thickness and stent coverage on each stent struts were evaluated. The mean NIH thickness was significantly greater in EES-treated lesions than in SES-treated lesions (115 ± 52 μm vs. 89 ± 58 μm, P = 0.001, respectively). The percentage of uncovered strut was significantly smaller in EES-treated lesions than in SES-treated lesions (4.4 ± 4.7% vs. 10.5 ± 12.7%, P = 0.016, respectively). There was no significant difference in the percentage of malapposed strut between the two groups (0.4 ± 0.8% in EES vs. 1.7 ± 4.5% in SES, P = 0.344). The incidence of intracoronary thrombus was significantly lower in EES-treated lesions than in SES-treated lesions (5.0% vs. 34.3%, P < 0.001, respectively). EES showed a significantly lower incidence of uncovered stent struts and intracoronary thrombus than SES in 9-month follow-up OCT examination. Compared to SES, EES might have more favorable vascular responses after stent implantation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Babapulle MN, Joseph L, Belisle P et al (2004) A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 364:583–591
Jeremias A, Sylvia B, Bridges J et al (2004) Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 109:1930–1932
Kim U, Kim JS, Kim JS et al (2010) The initial extent of malapposition in ST-elevation myocardial infarction treated with drug-eluting stent: the usefulness of optical coherence tomography. Yonsei Med J 51:332–338
Matsumoto D, Shite J, Shinke T et al (2007) Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 28:961–967
Takano M, Jang IK, Inami S et al (2008) In vivo comparison of optical coherence tomography and angioscopy for the evaluation of coronary plaque characteristics. Am J Cardiol 101:471–476
Kim JS, Kim JS, Kim TH et al (2010) Comparison of neointimal coverage of sirolimus-eluting stent and paclitaxel-eluting stent using optical coherence tomography at 9 months after implantation. Circ J 74:320–326
Kim JS, Jang IK, Kim JS et al (2009) Optical coherence tomography evaluation of zotarolimus-eluting stents at 9 month follow up: comparison with sirolimus-eluting stents. Heart 95:1907–1912
Stone GW, Rizvi A, Newman W et al (2010) Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med 362:1663–1674
Costa RA, Lansky AJ, Mintz GS et al (2005) Angiographic results of the first huma experience with everolimus-eluting stents for the treatment of coronary lesion (the FUTURE I trial). Am J Cardiol 95:113–116
Michael J, Gaku N, Finn AV et al (2008) Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 52:333–342
Takano M, Inami S, Jang IK et al (2007) Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol 99:1033–1038
Finn AV, Joner M, Nakazawa G et al (2007) Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115:2435–2441
Tanigawa J, Barlis P, Dimopoulos K et al (2008) The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography. Int J Cardiol 134:180–188
Kume T, Akasaka T, Kawamoto T et al (2006) Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 97:1713–1717
Prati F, Regar E, Mintz GS et al (2010) Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 31:401–415
Jang IK, Bouma BE, Kang DH et al (2002) Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol 39:604–609
Barlis P, Regar E, Serruys PW et al (2010) An optical coherence tomography study of a biodegradable versus durable polymer-coated limus- eluting stent: a LEADERS trial sub study. Euro Heart J 31:165–176
Jensen LO, Thayssen P, Hanse HS et al (2010) A prospective randomized trial of everolimus-eluting and sirolimus-eluting stents in patients with coronary artery disease (SORT OUT IV trial). J Am Coll Cardiol 56(suppl B):xiii
Acknowledgments
This study was partly supported by grants from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (No. A085012 and A102064), the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (No. A085136), and the Cardiovascular Research Center, Seoul, Korea.
Conflict of interest
All authors do not have any conflict of interest associated with this paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Choi, H.H., Kim, JS., Yoon, D.H. et al. Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography. Int J Cardiovasc Imaging 28, 491–497 (2012). https://doi.org/10.1007/s10554-011-9849-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-011-9849-7